Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma

Naugler Willscott E.

首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma

【24h】

Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma

机译：Battle Royale：全身性与型肝细胞癌的型患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE. This commentary discusses research examining comparisons of locoregional therapy with systemic therapy for unresectable hepatocellular carcinoma (HCC).

机译：客观的。该评论讨论了研究课程治疗对无法切除的肝细胞癌（HCC）的全身治疗的比较。

著录项

来源
《AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences》 |2018年第6期|共2页
作者
Naugler Willscott E.;
展开▼
作者单位

Oregon Hlth &

Sci Univ Dept Med 3181 SW Sam Jackson Pk Rd MC L461 Portland OR 97239 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
chemoembolization; hepatocellular carcinoma;

机译：化疗栓塞;肝细胞癌;

相似文献

外文文献
中文文献
专利

1. Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma [J] . Naugler Willscott E. AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2018,第6期

机译：Battle Royale：全身性与型肝细胞癌的型患者
2. Combined versus single locoregional therapy in the treatment of unresectable hepatocellular carcinoma [J] . Moustafa H.M. Othman, Amr F. Mourad, Mohamed M.H. Abd Ellah, The Egyptian Journal of Radiology and Nuclear Medicine . 2014,第2期

机译：局部局部联合疗法治疗不可切除的肝细胞癌
3. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma. [J] . Reidy DL, Schwartz JD Anti-cancer drugs . 2004,第5期

机译：不可切除的肝细胞癌的治疗：随机临床试验的回顾-I：不可切除的肝细胞癌的肝动脉栓塞和基于栓塞的治疗。
4. Nonrigid registration for evaluating locoregional therapy of hepatocellular carcinoma [C] . Dong Chunhua, Seki Toshihito, Inoguchi Ryosuke, International Conference on Biomedical Engineering and Informatics . 2013

机译：非刚性注册评估肝细胞癌局部治疗
5. The anti-cancer activities of Paeoniae Radix extracts on human hepatocellular carcinoma cell-line HepG2 and multidrug resistant human hepatocellular carcinoma cell-line R-HepG2 and their action mechanisms. [D] . Li, Lok Yee Mandy. 2004

机译：e药提取物对人肝癌细胞HepG2和多药耐药人肝癌细胞R-HepG2的抗癌活性及其作用机制。
6. Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma [O] . Syed Irfan‐Ur Rahman, Laura Nunez‐Herrero, Jamie Lee Berkes 2020

机译：位置2：经动脉放射栓塞术应成为不可切除的肝细胞癌的主要局部治疗
7. Combined versus single locoregional therapy in the treatment of unresectable hepatocellular carcinoma [O] . Moustafa H.M. Othman, Amr F. Mourad, Mohamed M.H. Abd Ellah, 2014

机译：联合与单局部治疗联合治疗不能切除的肝细胞癌

Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅